Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,357 | 657 | 98.7% |
| Travel and Lodging | $92.43 | 1 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27.19 | 1 | 0.2% |
| Education | $26.80 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $1,237 | 95 | $0 (2024) |
| ABBVIE INC. | $1,092 | 59 | $0 (2024) |
| UCB, Inc. | $728.56 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $483.75 | 27 | $0 (2024) |
| Lundbeck LLC | $459.97 | 22 | $0 (2021) |
| Biogen, Inc. | $453.47 | 28 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $448.80 | 29 | $0 (2024) |
| PFIZER INC. | $406.66 | 24 | $0 (2024) |
| Eisai Inc. | $400.10 | 22 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $367.97 | 34 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,056 | 53 | ABBVIE INC. ($387.30) |
| 2023 | $1,930 | 99 | ABBVIE INC. ($314.82) |
| 2022 | $1,674 | 94 | ACADIA Pharmaceuticals Inc ($458.57) |
| 2021 | $976.37 | 59 | Novartis Pharmaceuticals Corporation ($127.85) |
| 2020 | $388.47 | 24 | UCB, Inc. ($44.73) |
| 2019 | $1,290 | 86 | ACADIA Pharmaceuticals Inc ($167.61) |
| 2018 | $1,900 | 116 | GENZYME CORPORATION ($207.24) |
| 2017 | $2,289 | 130 | UCB, Inc. ($229.53) |
All Payment Transactions
661 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Neuropsychiatry | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: PAIN | ||||||
| 12/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PAIN | ||||||
| 11/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Neuromodulation | ||||||
| 10/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: PAIN | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Neurology | ||||||
| 09/30/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: PAIN | ||||||
| 08/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: NEUROSCIENCE | ||||||
| 08/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: PAIN | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $34.56 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Neurology | ||||||
| 07/30/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 07/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $31.23 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROLOGY | ||||||
| 07/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: PAIN | ||||||
| 07/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: PAIN | ||||||
| 07/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,142 | 3,494 | $1.0M | $365,633 |
| 2022 | 40 | 1,805 | 7,121 | $865,819 | $284,280 |
| 2021 | 35 | 1,716 | 6,842 | $816,868 | $289,784 |
| 2020 | 31 | 2,396 | 9,223 | $966,870 | $376,119 |
All Medicare Procedures & Services
138 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 338 | 695 | $229,532 | $91,102 | 39.7% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 316 | 386 | $198,800 | $77,969 | 39.2% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 12 | 36 | $111,200 | $29,938 | 26.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 95 | 97 | $70,582 | $27,684 | 39.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 64 | 66 | $54,130 | $21,396 | 39.5% |
| 95957 | Measurement of brain wave activity (eeg), digital analysis | Office | 2023 | 94 | 95 | $48,820 | $19,953 | 40.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 80 | 80 | $32,773 | $12,726 | 38.8% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 58 | 58 | $29,980 | $11,330 | 37.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 60 | 217 | $40,405 | $10,195 | 25.2% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 95 | 96 | $24,182 | $9,723 | 40.2% |
| 92652 | Evaluation of brain response to sound for determination of hearing threshold with interpretation and report | Office | 2023 | 94 | 95 | $20,370 | $8,325 | 40.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 41 | 41 | $14,840 | $5,804 | 39.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 35 | 78 | $13,968 | $5,598 | 40.1% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 94 | 95 | $12,000 | $4,785 | 39.9% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 33 | 33 | $7,686 | $3,089 | 40.2% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 12 | 12 | $10,250 | $2,495 | 24.3% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 95 | 96 | $6,233 | $2,432 | 39.0% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 14 | 14 | $6,659 | $2,417 | 36.3% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 24 | 24 | $8,504 | $2,327 | 27.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 33 | 33 | $5,066 | $2,047 | 40.4% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 30 | 30 | $4,959 | $2,016 | 40.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 12 | $4,476 | $1,798 | 40.2% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 14 | 14 | $4,056 | $1,552 | 38.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $3,430 | $1,379 | 40.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 22 | 31 | $3,553 | $1,301 | 36.6% |
About Dr. Joseph Oommen, MD
Dr. Joseph Oommen, MD is a Neurology healthcare provider based in Beaumont, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770518516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Oommen, MD has received a total of $11,504 in payments from pharmaceutical and medical device companies, with $1,056 received in 2024. These payments were reported across 661 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($11,357).
As a Medicare-enrolled provider, Oommen has provided services to 8,059 Medicare beneficiaries, totaling 26,680 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 138 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Beaumont, TX
- Active Since 07/11/2006
- Last Updated 09/12/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770518516
Products in Payments
- NUPLAZID (Drug) $1,237
- QULIPTA (Drug) $598.64
- Briviact (Drug) $553.81
- UBRELVY (Drug) $504.13
- NURTEC ODT (Drug) $500.70
- NORTHERA (Drug) $426.76
- APTIOM (Drug) $409.21
- KESIMPTA (Drug) $363.51
- Fycompa (Drug) $302.27
- VALTOCO (Drug) $288.62
- AUBAGIO (Drug) $252.36
- RYTARY (Drug) $230.74
- Horizant (Drug) $227.74
- Xadago (Drug) $211.32
- Gamunex-C (Biological) $209.31
- ACTIVA (Device) $191.07
- EPIDIOLEX (Drug) $161.91
- TYSABRI (Biological) $160.87
- TROKENDI XR (Drug) $149.52
- Vercise (Device) $140.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Beaumont
Dr. Kandasami Senthilkumar, M.d, M.D
Neurology — Payments: $424,794
Nestor Punay, M.d, M.D
Neurology — Payments: $215,714
Julius Deiparine, Md, MD
Neurology — Payments: $14,933
William High, Md, MD
Neurology — Payments: $13.35
Dr. Autumn Hardin, Dpt, DPT
Neurology